Review
doi: 10.1056/NEJMra1001389.
Triple-negative breast cancer
Affiliations
- PMID: 21067385
- DOI: 10.1056/NEJMra1001389
Item in Clipboard
Review
Triple-negative breast cancer
N Engl J Med.
.
Free article
Abstract
Triple-negative breast cancer, so called because it lacks expression of the estrogen receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast cancer. This review focuses on its origin, molecular and clinical characteristics, and treatment.
Similar articles
-
Triple-negative breast cancer: current state of the art.Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review.
-
Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189. Expert Rev Anticancer Ther. 2010. PMID: 20131996 Review.
-
What is triple-negative breast cancer?Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12. Eur J Cancer. 2008. PMID: 19008097 Review.
-
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.Clin Cancer Res. 2007 Apr 15;13(8):2329-34. doi: 10.1158/1078-0432.CCR-06-1109. Clin Cancer Res. 2007. PMID: 17438091
-
Pharmacotherapy of triple-negative breast cancer.Expert Opin Pharmacother. 2009 Sep;10(13):2081-93. doi: 10.1517/14656560903117309. Expert Opin Pharmacother. 2009. PMID: 19640211 Review.
Cited by
-
lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis.Onco Targets Ther. 2021 Apr 20;14:2747-2759. doi: 10.2147/OTT.S293832. eCollection 2021. Onco Targets Ther. 2021. PMID: 33907418 Free PMC article.
-
The Usefulness of the Pretreatment Neutrophil/Lymphocyte Ratio as a Predictor of the 5-Year Survival in Stage 1-3 Triple Negative Breast Cancer Patients.Breast Care (Basel). 2021 Feb;16(1):43-49. doi: 10.1159/000506463. Epub 2020 Apr 14. Breast Care (Basel). 2021. PMID: 33716631 Free PMC article.
-
The use of nanomaterials as drug delivery systems and anticancer agents in the treatment of triple-negative breast cancer: an updated review (year 2005 to date).Discov Nano. 2024 Sep 3;19(1):138. doi: 10.1186/s11671-024-04089-3. Discov Nano. 2024. PMID: 39225730 Free PMC article. Review.
-
Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period.Breast Cancer Res Treat. 2021 Aug;189(1):225-236. doi: 10.1007/s10549-021-06246-z. Epub 2021 May 8. Breast Cancer Res Treat. 2021. PMID: 33966182 Review.
-
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.J Hematol Oncol. 2022 Oct 8;15(1):143. doi: 10.1186/s13045-022-01362-9. J Hematol Oncol. 2022. PMID: 36209184 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
